Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Assets Average (2021 - 2025)

Bioventus' Assets Average history spans 5 years, with the latest figure at $692.6 million for Q4 2025.

  • For Q4 2025, Assets Average fell 7.5% year-over-year to $692.6 million; the TTM value through Dec 2025 reached $692.6 million, down 7.5%, while the annual FY2025 figure was $705.8 million, 8.28% down from the prior year.
  • Assets Average reached $692.6 million in Q4 2025 per BVS's latest filing, down from $704.2 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.4 billion in Q4 2022 to a low of $568.8 million in Q2 2021.
  • Average Assets Average over 5 years is $873.3 million, with a median of $797.9 million recorded in 2024.
  • Peak YoY movement for Assets Average: soared 113.0% in 2022, then crashed 41.46% in 2023.
  • A 5-year view of Assets Average shows it stood at $940.3 million in 2021, then skyrocketed by 47.33% to $1.4 billion in 2022, then plummeted by 41.46% to $811.0 million in 2023, then decreased by 7.68% to $748.7 million in 2024, then fell by 7.5% to $692.6 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Assets Average are $692.6 million (Q4 2025), $704.2 million (Q3 2025), and $699.1 million (Q2 2025).